Benchmark Electronics, Inc. — Q2 2022 Form 10-Q
Reporting period: Three and six months ended June 30, 2022; comparisons are with the corresponding 2021 periods. Benchmark provides advanced manufacturing, design and engineering, and technology solutions to OEMs across aerospace and defense, medical, industrial, semiconductor equipment, computing and telecommunications markets. Amounts below are in millions unless otherwise noted.
Financial performance
| Metric | Q2 2022 | Q2 2021 | H1 2022 | H1 2021 |
|---|---|---|---|---|
| Sales | $728.0 | $544.7 | $1,364.1 | $1,050.4 |
| Gross profit | $58.8 | $47.9 | $116.4 | $90.1 |
| Gross margin | 8.1% | 8.8% | 8.5% | 8.6% |
| Operating income | $22.4 | $10.7 | $37.8 | $22.6 |
| Operating margin | 3.2% | 2.0% | 2.8% | 2.2% |
| Net income | $17.2 | $7.4 | $28.2 | $15.3 |
| Diluted EPS | $0.49 | $0.20 | $0.79 | $0.42 |
Q2 sales grew 34% year over year; operating income more than doubled. Gross margin contracted as revenue mix, supply-chain disruption and low/no-margin supply premiums weighed on profitability. SG&A rose to $35.8 million in Q2 and $72.1 million in H1, partly reflecting variable compensation, medical claims and IT investment. H1 effective tax rate was 19.0%, versus 20.1% a year earlier.
Cash flow, balance sheet and capital allocation
- Cash from operations was negative $93.5 million in H1, versus positive $40.3 million in H1 2021. Working-capital investment was the principal drag: inventory increased $146.2 million, receivables $91.2 million and contract assets $23.9 million. Payables and customer advances partially offset these uses.
- Investing cash outflow was $19.3 million; capital expenditures were $23.2 million. Financing provided $110.8 million, including $398.0 million of credit-agreement borrowings and $263.0 million of repayments.
- Cash and restricted cash totaled $263.9 million at June 30, 2022, down from $271.7 million at year-end 2021. Working capital was approximately $0.8 billion, compared with $0.7 billion at year-end.
- Total debt carrying value was $264.8 million, comprising $131.3 million term debt and $135.0 million revolving borrowings, net of debt issuance costs and including current installments. The revolving facility was increased to $450 million in May; $311.1 million remained available, subject to covenants. The company reported covenant compliance.
- Shareholders’ equity was $985.8 million. H1 dividends paid were $11.6 million; share repurchases were $9.4 million, with $154.6 million remaining under authorization. Quarterly dividend was $0.165 per share.
Material changes and business drivers
- H1 sales increased 30%. Q2 growth was broad: Industrials +59%, Medical +53%, Computing +73%, Semi-Cap +26% and Telecommunications +15%; A&D declined 7%.
- Asia segment revenue rose 44% in Q2, Americas 23% and Europe 35%. Asia operating income rose 17%; Europe operating income declined 41%, primarily due to sales mix.
- Sales to the ten largest customers increased to 53% of H1 sales from 46% in H1 2021, increasing customer-concentration exposure.
- Inventory rose to $666.7 million from $523.2 million at year-end, while customer advance payments rose to $173.6 million from $118.1 million. Management attributed working-capital growth to investment supporting higher demand amid component constraints.
Outlook, risks and unusual items
- Management said current demand indicators supported continued momentum through H2 2022 and expected strength in Semi-Cap in 2023. The filing text provided references Q3 2022 guidance but does not provide a clear guidance value.
- Management expected capital expenditures of approximately $50–$60 million over the next 12 months, mainly for equipment and capacity. It believed cash, operating cash flow and available borrowing capacity would meet liquidity needs for at least the next 12 months.
- COVID-related disruption, component shortages and allocation, extended lead times, labor constraints, inflation and higher freight or component costs continued to constrain production and create operational inefficiencies. Management noted some easing of material constraints but ongoing uncertainty.
- Restructuring activity included site closures and workforce reductions. H1 restructuring charges were $3.6 million before related asset-sale effects; Angleton operations and restructuring were complete, while the Moorpark closure was expected by year-end. The income statement reported a net restructuring and other-cost credit of $1.1 million for Q2 and a net expense of $3.2 million for H1.
- The company had $9.6 million reserved for uncertain tax benefits. Tax incentives reduced H1 tax expense by about $1.7 million; the Malaysia tax-holiday extension was not assured. Applied-for employee retention tax credits had not yet been received.
- Management reported ordinary-course legal matters not expected to materially affect financial position or results. No further ransomware insurance recoveries were expected. The company reported effective disclosure controls and no material change in internal control over financial reporting; ERP upgrades will continue in phases.
Key facts for investors to verify
- Whether supply-chain and labor constraints ease enough to convert customer demand into shipments and operating cash flow.
- Inventory levels, receivables, contract assets and customer advances, and whether working capital normalizes after the H1 cash outflow.
- Realized margins as revenue mix changes and supply-chain premiums and ramp-related inefficiencies evolve.
- Customer concentration and the sustainability of growth by sector, particularly the decline in A&D and the strength in Semi-Cap.
- Debt, borrowing availability and covenant headroom under the amended credit facility, including exposure to floating rates despite the interest-rate swap.
- Actual Q3 results and any specific guidance, which are not clearly stated in the supplied filing text; also verify capital spending, dividend and repurchase plans against future cash generation.